Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Neoplasms | 5 | 2018 | 352 | 2.100 |
Why?
|
| Colorectal Neoplasms | 7 | 2016 | 237 | 1.870 |
Why?
|
| Hepatectomy | 3 | 2018 | 33 | 1.200 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2018 | 203 | 0.970 |
Why?
|
| Hand-Assisted Laparoscopy | 2 | 2012 | 2 | 0.860 |
Why?
|
| Postoperative Complications | 5 | 2023 | 1035 | 0.720 |
Why?
|
| Hepatomegaly | 1 | 2018 | 10 | 0.640 |
Why?
|
| Nipples | 1 | 2017 | 34 | 0.620 |
Why?
|
| Organ Sparing Treatments | 1 | 2017 | 54 | 0.600 |
Why?
|
| Embolization, Therapeutic | 1 | 2018 | 98 | 0.580 |
Why?
|
| Mastectomy | 1 | 2017 | 143 | 0.570 |
Why?
|
| Colonic Neoplasms | 2 | 2023 | 164 | 0.560 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 52 | 0.550 |
Why?
|
| Retrospective Studies | 14 | 2023 | 6460 | 0.540 |
Why?
|
| Patient Readmission | 3 | 2023 | 242 | 0.540 |
Why?
|
| Continuity of Patient Care | 2 | 2015 | 63 | 0.540 |
Why?
|
| Hemorrhage | 2 | 2023 | 209 | 0.530 |
Why?
|
| Vascular Surgical Procedures | 2 | 2013 | 178 | 0.470 |
Why?
|
| Laparoscopy | 2 | 2013 | 188 | 0.440 |
Why?
|
| Health Services for the Aged | 1 | 2012 | 38 | 0.430 |
Why?
|
| Patient Discharge | 3 | 2023 | 353 | 0.430 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2012 | 21 | 0.420 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2012 | 36 | 0.410 |
Why?
|
| Surgical Wound Infection | 2 | 2013 | 126 | 0.410 |
Why?
|
| Aged | 14 | 2018 | 10061 | 0.410 |
Why?
|
| Vascular Diseases | 1 | 2012 | 77 | 0.410 |
Why?
|
| Aged, 80 and over | 8 | 2018 | 3431 | 0.370 |
Why?
|
| Middle Aged | 12 | 2023 | 13083 | 0.360 |
Why?
|
| Multivariate Analysis | 6 | 2015 | 643 | 0.360 |
Why?
|
| Male | 18 | 2023 | 27348 | 0.360 |
Why?
|
| Female | 18 | 2023 | 28474 | 0.350 |
Why?
|
| Humans | 25 | 2023 | 54397 | 0.340 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1249 | 0.320 |
Why?
|
| Risk Factors | 8 | 2023 | 3937 | 0.290 |
Why?
|
| Logistic Models | 5 | 2016 | 991 | 0.250 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2016 | 305 | 0.250 |
Why?
|
| Ileus | 1 | 2023 | 16 | 0.240 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2023 | 172 | 0.210 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 75 | 0.210 |
Why?
|
| Liver Cirrhosis | 2 | 2016 | 218 | 0.200 |
Why?
|
| United States | 4 | 2016 | 5209 | 0.200 |
Why?
|
| Hospitals, Veterans | 2 | 2016 | 125 | 0.170 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 164 | 0.160 |
Why?
|
| Proportional Hazards Models | 3 | 2016 | 430 | 0.160 |
Why?
|
| Eligibility Determination | 1 | 2017 | 17 | 0.160 |
Why?
|
| Mammaplasty | 1 | 2017 | 45 | 0.150 |
Why?
|
| Tumor Burden | 1 | 2017 | 141 | 0.150 |
Why?
|
| Ileostomy | 1 | 2016 | 7 | 0.150 |
Why?
|
| Odds Ratio | 3 | 2015 | 600 | 0.150 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2016 | 23 | 0.150 |
Why?
|
| Liver | 1 | 2023 | 1226 | 0.150 |
Why?
|
| Prospective Studies | 1 | 2023 | 2606 | 0.150 |
Why?
|
| Models, Theoretical | 1 | 2018 | 184 | 0.140 |
Why?
|
| Time Factors | 3 | 2013 | 3210 | 0.140 |
Why?
|
| Treatment Outcome | 4 | 2016 | 5612 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 35 | 0.140 |
Why?
|
| Carcinoma, Papillary | 1 | 2016 | 65 | 0.140 |
Why?
|
| Kinetics | 1 | 2018 | 692 | 0.140 |
Why?
|
| Rupture, Spontaneous | 1 | 2016 | 26 | 0.140 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2009 | 318 | 0.140 |
Why?
|
| Operative Time | 2 | 2013 | 76 | 0.140 |
Why?
|
| Back Pain | 1 | 2016 | 44 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 302 | 0.130 |
Why?
|
| Texas | 2 | 2013 | 160 | 0.130 |
Why?
|
| Autistic Disorder | 1 | 2007 | 135 | 0.130 |
Why?
|
| Abdominal Pain | 1 | 2016 | 84 | 0.130 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 89 | 0.130 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 276 | 0.130 |
Why?
|
| Blood Loss, Surgical | 2 | 2013 | 79 | 0.130 |
Why?
|
| Postoperative Care | 1 | 2015 | 121 | 0.120 |
Why?
|
| Lymph Node Excision | 2 | 2013 | 140 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 489 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 693 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 234 | 0.120 |
Why?
|
| Melanoma | 1 | 2017 | 313 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 2390 | 0.120 |
Why?
|
| Comorbidity | 2 | 2013 | 664 | 0.120 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 182 | 0.120 |
Why?
|
| Health Services Needs and Demand | 1 | 2015 | 190 | 0.110 |
Why?
|
| Rectal Neoplasms | 1 | 2013 | 51 | 0.110 |
Why?
|
| Vascular Grafting | 1 | 2012 | 6 | 0.110 |
Why?
|
| Hospital Mortality | 2 | 2012 | 466 | 0.110 |
Why?
|
| Robotics | 1 | 2013 | 45 | 0.110 |
Why?
|
| Neoplasms | 1 | 2023 | 1322 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2013 | 53 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2016 | 386 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2013 | 126 | 0.110 |
Why?
|
| Endarterectomy, Carotid | 1 | 2012 | 59 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 318 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 404 | 0.100 |
Why?
|
| Rectum | 1 | 2012 | 52 | 0.100 |
Why?
|
| Blood Transfusion | 1 | 2013 | 138 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 532 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 232 | 0.100 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2011 | 46 | 0.100 |
Why?
|
| Peripheral Arterial Disease | 1 | 2013 | 88 | 0.100 |
Why?
|
| Colon | 1 | 2012 | 111 | 0.100 |
Why?
|
| Prognosis | 2 | 2015 | 2126 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2011 | 222 | 0.090 |
Why?
|
| Veterans | 2 | 2013 | 619 | 0.090 |
Why?
|
| Incidence | 1 | 2012 | 1084 | 0.080 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 805 | 0.080 |
Why?
|
| Age Factors | 1 | 2012 | 1199 | 0.080 |
Why?
|
| Length of Stay | 1 | 2011 | 683 | 0.080 |
Why?
|
| Adult | 3 | 2016 | 14210 | 0.080 |
Why?
|
| Propensity Score | 2 | 2016 | 137 | 0.060 |
Why?
|
| Anastomotic Leak | 1 | 2023 | 10 | 0.060 |
Why?
|
| Colectomy | 1 | 2023 | 33 | 0.060 |
Why?
|
| Aftercare | 1 | 2023 | 82 | 0.050 |
Why?
|
| Young Adult | 1 | 2012 | 4319 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2023 | 270 | 0.050 |
Why?
|
| Peer Review, Health Care | 1 | 2009 | 1 | 0.050 |
Why?
|
| Hospitals, Special | 1 | 2009 | 9 | 0.050 |
Why?
|
| Education, Continuing | 1 | 2009 | 22 | 0.050 |
Why?
|
| Reimbursement, Incentive | 1 | 2009 | 14 | 0.040 |
Why?
|
| Personnel, Hospital | 1 | 2009 | 23 | 0.040 |
Why?
|
| Accreditation | 1 | 2009 | 73 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 1547 | 0.040 |
Why?
|
| Motor Skills Disorders | 1 | 2007 | 3 | 0.040 |
Why?
|
| Language Disorders | 1 | 2007 | 9 | 0.040 |
Why?
|
| Empathy | 1 | 2007 | 48 | 0.040 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2017 | 127 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2007 | 159 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 295 | 0.040 |
Why?
|
| Social Behavior | 1 | 2007 | 83 | 0.040 |
Why?
|
| Affect | 1 | 2007 | 104 | 0.040 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 256 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 164 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 127 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2007 | 240 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 445 | 0.030 |
Why?
|
| Prevalence | 1 | 2007 | 1026 | 0.030 |
Why?
|
| Mass Screening | 1 | 2007 | 370 | 0.030 |
Why?
|
| Respiration Disorders | 1 | 2013 | 25 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 736 | 0.030 |
Why?
|
| Chemoradiotherapy | 1 | 2013 | 42 | 0.030 |
Why?
|
| Learning Curve | 1 | 2012 | 22 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2013 | 125 | 0.030 |
Why?
|
| Survival Rate | 1 | 2015 | 954 | 0.030 |
Why?
|
| Registries | 1 | 2015 | 554 | 0.030 |
Why?
|
| Linear Models | 1 | 2012 | 308 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 91 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 514 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2011 | 189 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 1222 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2011 | 183 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 423 | 0.020 |
Why?
|
| Infant | 1 | 2007 | 3830 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2007 | 4158 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2013 | 1362 | 0.020 |
Why?
|